Indexado en

Licencia y uso

Citaciones

Altmetrics

Grant support

This work was supported by the Instituto de Salud Carlos III, Ministry of Health, Madrid, Spain [ICI19/00020; PI20/01221; RD21/002/0001]. The sponsor or funding organization had no role in the design or conduct of this research. The journal's Rapid Service Fee was funded by the institution employing the senior author of the manuscript (Fundacio ' n Biome ' dica del Hospital Cli ' nico San Carlos).

Análisis de autorías institucional

Compartir

Therapeutic Response After Immunosuppressive Drug Prescription in Non-infectious Uveitis: A Survival Analysis

Publicado en:Ophthalmology And Therapy. - 2022-10-20 (), DOI: 10.1007/s40123-022-00587-8

Autores: Gomez-Gomez, Alejandro; Madrid-Garcia, Alfredo; Borrego-Sanz, Lara; Alvarez-Hernandez, Paula; Arriola-Villalobos, Pedro; Perez-Sancristobal, Ines; Benitez del Castillo, Jose M.; Mendez-Fernandez, Rosalia; Pato-Cour, Esperanza; Diaz-Valle, David; Rodriguez-Rodriguez, Luis;

Afiliaciones

Resumen

Introduction To identify factors affecting the response rate to immunosuppressive drugs (ISDs) in patients with non-infectious uveitis (NIU). Methods This longitudinal retrospective cohort study included patients from the Hospital Clinico San Carlos Uveitis Clinic diagnosed with NIU from 1992 to 2016. Subjects were followed up from ISD prescription until the achievement of good therapeutic response (GTR), ISD treatment change, or up to 12 months. GTR was defined as the complete resolution of the eye inflammatory manifestations with a corticosteroid dose <= 10 or <= 5 mg per day of prednisone or equivalent (GTR10 and GTR5, respectively) maintained for at least 28 days. Kaplan-Meier curves were estimated for GTR. Demographic, clinical, and treatment-related factors were analyzed using Cox robust regression. Results A total of 73 patients (100 episodes of ISD prescription) were analyzed. In 44 and 41 episodes, GTR10 and GTR5 were achieved, respectively. A lower hazard for both GTRs was associated with uveitic macular edema at prescription and with a higher "highest oral corticosteroid dose prescribed in the year before ISD prescription". GTR10 was higher if cyclosporine was prescribed (compared to other ISDs), and if a higher number of ISDs had been previously prescribed. GTR5 hazard was lower for patients with posterior uveitis or if the ISDs were prescribed before 2008, and higher if periocular corticosteroids had been administered before ISD prescription, or if the duration of the posterior segment activity was shorter. Conclusions Factors associated with GTR to ISDs may help to identify patients with NIUs who could benefit from a thorough follow-up.

Palabras clave